Gyre Therapeutics, Inc. (GYRE) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $7.83 (+1.95%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Oct 10, 2025 | Roger Song | Jefferies | $16.00 | +104.3% |
Top Analysts Covering GYRE
GYRE vs Sector & Market
| Metric | GYRE | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | — | 2.24 | 2.41 |
| Analyst Count | — | 8 | 18 |
| Target Upside | +117.1% | +1150.1% | +14.9% |
| P/E Ratio | 348.00 | 6.54 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $23M | $33M | $43M | 2 |
| 2026-09-30 | $25M | $35M | $48M | 1 |
| 2026-12-31 | $27M | $37M | $51M | 1 |
| 2027-12-31 | $115M | $133M | $157M | 1 |
| 2028-12-31 | $380M | $437M | $518M | 1 |
| 2029-12-31 | $231M | $266M | $315M | 1 |
| 2030-12-31 | $269M | $310M | $368M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.08 | $-0.05 | $-0.03 | 2 |
| 2026-09-30 | $-0.12 | $-0.08 | $-0.05 | 1 |
| 2026-12-31 | $-0.14 | $-0.10 | $-0.06 | 1 |
| 2027-12-31 | $-0.24 | $-0.20 | $-0.16 | 1 |
| 2028-12-31 | $1.42 | $1.71 | $2.12 | 1 |
| 2029-12-31 | $0.09 | $0.11 | $0.14 | 1 |
| 2030-12-31 | $0.21 | $0.25 | $0.31 | 1 |
Frequently Asked Questions
What is the analyst consensus for GYRE?
The consensus among 0 analysts covering Gyre Therapeutics, Inc. (GYRE) is — with an average price target of $16.00.
What is the highest price target for GYRE?
The highest price target for GYRE is $16.00, set by Roger Song at Jefferies on 2025-10-10.
What is the lowest price target for GYRE?
The lowest price target for GYRE is $16.00, set by Roger Song at Jefferies on 2025-10-10.
How many analysts cover GYRE?
0 analysts have issued ratings for Gyre Therapeutics, Inc. in the past 12 months.
Is GYRE a buy or sell right now?
Based on 0 analyst ratings, GYRE has a consensus rating of — with a +117.1% upside to the consensus target of $16.00.
What are the earnings estimates for GYRE?
Analysts estimate GYRE will report EPS of $-0.05 for the period ending 2026-06-30, with revenue estimated at $33M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.